N- and C-domains of HIV-1 gp41: mutation, structure and functions (Q34134579)

31 July 2017

1 reference

title

N- and C-domains of HIV-1 gp41: mutation, structure and functions (English)

1 reference

31 July 2017

Dong XN

1

1 reference

31 July 2017

Xiao Y

series ordinal

2

1 reference

31 July 2017

Dierich MP

series ordinal

3

1 reference

31 July 2017

Chen YH

series ordinal

4

1 reference

31 July 2017

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

75

1 reference

31 July 2017

215-220

1 reference

31 July 2017

3

1 reference

HIV entry and its inhibition

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

HIV-1 inhibition by a peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

HIV-1 entry inhibitors in the side pocket

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

HIV. See a pocket, block it

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

1 reference

7 January 2021

Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

HIV vaccines. Magic of the occult?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Oligomerization of the hydrophobic heptad repeat of gp41.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

A common epitope on gp41, IFN-alpha and IFN-beta induces protective activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

1 reference

7 January 2021

Capture of an early fusion-active conformation of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Buried polar interactions and conformational stability in the simian immunodeficiency virus (SIV) gp41 core

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Epitope vaccine: a new strategy against HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900302-3

7 January 2021

10.1016/S0165-2478(00)00302-3

Identifiers

DOI

1 reference

31 July 2017

1 reference